{"id":"https://openalex.org/W93672847","doi":null,"title":"[Recurrence of non-small cell lung cancer after successful treatment with gefitinib--report of three cases].","display_name":"[Recurrence of non-small cell lung cancer after successful treatment with gefitinib--report of three cases].","publication_year":2004,"publication_date":"2004-08-01","ids":{"openalex":"https://openalex.org/W93672847","mag":"93672847","pmid":"https://pubmed.ncbi.nlm.nih.gov/15332545"},"language":"ja","primary_location":{"id":"pmid:15332545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15332545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111528873","display_name":"Sakuo Hoshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156752","display_name":"JR Tokyo General Hospital","ror":"https://ror.org/043p8z282","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210156752"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sakuo Hoshi","raw_affiliation_strings":["Dept of Respiratory Medicine, JR Tokyo General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Respiratory Medicine, JR Tokyo General Hospital","institution_ids":["https://openalex.org/I4210156752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085279682","display_name":"Tetsuo Yamaguchi","orcid":"https://orcid.org/0000-0002-9641-4894","observed_orcids":["https://orcid.org/0000-0002-9641-4894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuo Yamaguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000252461","display_name":"Chiyoko Kono","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiyoko Kono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Hiroko Amano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroko Amano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075430481","display_name":"Yoshihito Yamada","orcid":"https://orcid.org/0000-0003-4370-7594","observed_orcids":["https://orcid.org/0000-0003-4370-7594"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshihito Yamada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.01354282,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"31","issue":"8","first_page":"1209","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.4440000057220459},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.7979999780654907},{"id":"https://openalex.org/keywords/egfr-tki-resistance","display_name":"EGFR tyrosine kinase inhibitor resistance","score":0.7770000100135803},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.8659999966621399},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.6420000195503235},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9969204664230347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7950549125671387},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7181280255317688},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6205803155899048},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5458377599716187},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5280963778495789},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.46359696984291077},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3568611145019531}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15332545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15332545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},{"id":"mag:93672847","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15332545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2065576471","https://openalex.org/W178555968","https://openalex.org/W272376553","https://openalex.org/W1998152832","https://openalex.org/W2425508265","https://openalex.org/W4414096059","https://openalex.org/W3197430676","https://openalex.org/W1976056806","https://openalex.org/W1989136035","https://openalex.org/W2026600167"],"abstract_inverted_index":{"Gefitinib,":[0],"a":[1,74],"first":[2,155],"epidermal":[3],"growth":[4],"factor":[5],"receptor":[6],"(EGFR)":[7],"inhibitor":[8],"has":[9,110],"been":[10,111,144],"reported":[11],"to":[12,26,91,150,182],"be":[13,183],"effective":[14,132],"in":[15,73,89,136,157,170,193],"chemotherapy-resistant":[16],"non-small":[17,54,161],"cell":[18,55,162],"lung":[19,34,56,163],"cancer.":[20],"Gefitinib":[21],"was":[22,98,116,121,134],"also":[23],"reported,":[24],"however,":[25,130],"produce":[27],"severe":[28],"adverse":[29],"effects,":[30],"such":[31],"as":[32],"interstitial":[33],"disease.":[35],"Thus,":[36],"clinical":[37,187],"evaluation":[38,188],"of":[39,53,69,105,138,147,168,189,195,200],"gefitinib":[40,66,101,151,190],"is":[41,180],"still":[42],"controversial":[43],"and":[44,79,81,191],"further":[45],"studies":[46],"are":[47],"needed.":[48],"We":[49],"present":[50],"3":[51,90,115,140],"cases":[52],"cancer":[57],"(stage":[58],"IV":[59],"adeno-carcinoma)":[60],"that":[61],"showed":[62,87],"recurrence":[63,88,169],"after":[64,76,172],"successful":[65,173],"treatment.":[67],"Symptoms":[68],"all":[70,86],"patients":[71,158,171],"ameliorated":[72],"week":[75],"the":[77,103,106,139,154,186,198],"therapy,":[78],"radiograph":[80],"laboratory":[82],"data":[83],"improved.":[84],"However,":[85],"7":[92],"months.":[93],"After":[94,128],"recurrence,":[95,129],"patient":[96],"1":[97],"re-treated":[99],"with":[100,118,159,175],"at":[102,153],"request":[104],"patient.":[107],"Patient":[108,114],"2":[109],"on":[112],"gefitinib.":[113,201],"treated":[117],"gefitinib,":[119],"which":[120],"later":[122],"replaced":[123],"by":[124],"another":[125],"chemotherapy":[126],"agent.":[127,177],"no":[131],"response":[133,149],"obtained":[135],"any":[137],"cases.":[141],"There":[142],"have":[143],"several":[145],"reports":[146,167],"good":[148],"therapy":[152,174],"time":[156],"advanced":[160],"cancer,":[164],"but":[165],"few":[166],"this":[176],"This":[178],"report":[179],"thought":[181],"important":[184],"for":[185],"useful":[192],"terms":[194],"information":[196],"about":[197],"resistance":[199]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}